Skip to main content
SpringerLink
Log in

Unintended serum lipid level changes induced by some commonly used drugs

  • Drug reactions and interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mantel-Teeuwisse AK, Kloosterman JME, Maitland-van der Zee, AH, et al. Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf 2001, 24: 443–56

    Article  PubMed  CAS  Google Scholar 

  2. Periard D, Telenti A, Sudre P, et al. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation 1999; 100: 700–5

    Article  PubMed  CAS  Google Scholar 

  3. Lakshman MR, Reda DJ, Materson BJ, et al. Diuretics and β-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Arch Intern Med 1999; 159: 551–8

    Article  PubMed  CAS  Google Scholar 

  4. Kasiske BL, Ma JZ, Kalil RSN, et al. Effects of antihypertensive therapy on serum lipids. Ann Intern Med 1995; 122: 133–41

    PubMed  CAS  Google Scholar 

  5. Howes LG, Lykos D, Rennie GC. Effects of antihypertensive drugs on coronary artery disease risk: a meta analysis. Clin Exp Pharmacol Physiol 1996; 23: 555–8

    Article  PubMed  CAS  Google Scholar 

  6. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack trial (ALLHAT). JAMA 2000; 283: 1967–75

    Article  Google Scholar 

  7. Ravid M, Neumann L, Lishner M. Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors. Kidney Int 1995; 47: 907–10

    Article  PubMed  CAS  Google Scholar 

  8. Jick H, Jick SS, Gurewich V, et al. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen compounds. Lancet 1995; 346: 1589–93

    Article  PubMed  CAS  Google Scholar 

  9. Hannaford P. Cardiovascular events associated with different combined oral contraceptives: a review of current data. Drug Saf 2000; 22: 361–71

    Article  PubMed  CAS  Google Scholar 

  10. Herings RM, Urquhart J, Leufkens HG. Venous thromboembolism among new users of different oral contraceptives [published erratum appears in Lancet 1999 Oct 23; 354 (9188): 1478]. Lancet 1999; 354: 127–8

    Article  PubMed  CAS  Google Scholar 

  11. Barth JH, Macdonald-Hull SP, Mark J, et al. Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993; 129: 704–7

    Article  PubMed  CAS  Google Scholar 

  12. Sasaki J, Funakoshi M, Arakawa K. Lipids and apolipoproteins in patients treated with major tranquilizers. Clin Pharmacol Ther 1985; 37: 684–7

    Article  PubMed  CAS  Google Scholar 

  13. Bergemann N, Ehrig C, Diebold K, et al. Asymptomatic pancreatitis associated with clozapine. Pharmacopsychiatry 1999; 32: 78–80

    Article  PubMed  CAS  Google Scholar 

  14. Zeitlhofer J, Doppelbauer A, Tribl G, et al. Changes of serum lipid patterns during long-term anticonvulsive treatment. Clin Invest 1993; 71: 574–8

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Unintended serum lipid level changes induced by some commonly used drugs. Drugs Ther. Perspect 17, 11–15 (2001). https://doi.org/10.2165/00042310-200117230-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200117230-00004

Keywords

Search

Navigation